New potential therapeutic strategy against a very aggressive infant bone cancer

(IDIBELL-Bellvitge Biomedical Research Institute) Researchers at the Bellvitge Biomedical Research Institute, led by Oscar Martínez Tirado participated in an international study which suggests inhibition of Sirtuin1 protein as a future treatment option for metastatic Ewing sarcoma. The results of the study were published in the journal Cancer Research.

http://www.eurekalert.org/pub_releases/2015-01/ibri-npt012915.php

Source: EurekAlert! - Cancer - January 29, 2015 Category: Cancer & Oncology Source Type: news